Distinguished Scholars

The renowned Distinguished Scholars program supports scientists who are at the very top in their field and at the forefront of today’s most exciting breakthroughs in pancreatic cancer research. Each grantee receives $5 million in funding over five years, enabling them to dedicate more of their time and focus to pancreatic cancer and pursue high-risk, high-reward research.

Lustgarten’s funding and support of this research has led to a revolution in understanding the disease, enabling new approaches to diagnosis and treatment.

Meet the Researchers

Ronald M. Evans, Ph.D.
Douglas Fearon, M.D.
Bert Vogelstein, M.D.

Thanks for signing up!
Tell us a little more about yourself: